Surgical Risks
- Bleeding
- Changes in blood pressure during surgery
- Problems with wound healing
- Injury to nearby organs
- Infection
- Pulmonary embolism (blood clots that can travel to the lungs)
- Heart-related complications, such as a heart attack or irregular heartbeat
- Death, in rare cases
Immunosuppressant Drug Side Effects
To keep your new kidney healthy, you’ll need to take anti-rejection medications, called immunosuppressants, for the rest of your life after the transplant, says Rafael Villicana, MD, a nephrologist and the medical director of kidney transplantation at Loma Linda University Health in San Bernardino, California.
In the first several months after a transplant, when immunosuppression is at its highest, your care team will monitor you closely and may prescribe medications like antibiotics to prevent infections, says Ryan. Even after that window, your infection risk remains higher than average, which means it’s important to seek care promptly if you develop symptoms, including a fever, she adds.
Immunosuppressants can also increase the risk of certain health conditions, including diabetes, high blood pressure, and elevated cholesterol, says Haririan. To help manage potential medication side effects, notify your care team about any new or changing symptoms.
IgAN Recurrence After Transplant
But recurrence does not automatically mean the transplanted kidney will fail. Ryan notes that some recurrences are mild and cause no problems, while others lead to rapid kidney dysfunction and eventual failure. When caught early, IgAN recurrence can be treated, Villicana says.
Some of the immunosuppressive medications used to prevent rejection may also help reduce the risk of recurrence, says Ali, adding that there are now more treatment options for IgAN than in the past.
For these reasons, staying consistent with your medications and keeping up with medical appointments remains an important part of life after transplant. This allows your care team to monitor for recurrence and address any concerns early.

